---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-008731"
form_type: "8-K"
ticker: "XBIO"
cik: "0001534525"
company_name: "Xenetic Biosciences, Inc."
filed_at: "2023-12-08T23:59:59+00:00"
generated_at: "2026-06-07T15:34:21.801097+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Xenetic Biosciences shareholders reject non-binding say-on-pay proposal at 2023 annual meeting

## Summary
- Nine director nominees elected; Dr. Dmitry Genkin received highest 'for' votes (461,413), Jeffrey Eisenberg lowest (255,632).
- Ratification of Marcum LLP as auditor approved with 804,522 for, 21,792 against.
- Say-on-pay advisory proposal failed: 153,605 for, 318,665 against, 2,112 abstained; received less than one-third of votes cast.
- Broker non-votes of 356,015 on director elections and say-on-pay due to routine/non-routine mix.

## SEC filing metadata
- accession: 0001683168-23-008731
- form_type: 8-K
- ticker: XBIO
- cik: 0001534525
- company_name: Xenetic Biosciences, Inc.
- filed_at: 2023-12-08T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534525/000168316823008731/0001683168-23-008731-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534525/000168316823008731/xenetic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-008731
- JSON: https://secwatch.observer/filing/0001683168-23-008731.json
- Plain text: https://secwatch.observer/filing/0001683168-23-008731.txt

## Key facts
- Shareholder Votes
  Xenetic Biosciences, Inc. shareholders approved Election of nine nominees to the Board of Directors at the 2023-12-06 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-12-06
  source text: The Company’s stockholders approved the election of the following nine nominees with each director receiving votes as follows:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534525/000168316823008731/0001683168-23-008731-index.htm
- Shareholder Votes
  Xenetic Biosciences, Inc. shareholders rejected Advisory vote on named executive officer compensation at the 2023-12-06 meeting.
  - Proposal: say on pay
  - Outcome: failed
  - Meeting: 2023-12-06
  source text: The Company’s stockholders voted upon, on a non-binding, advisory basis, the Company’s named executive officer compensation. The proposal did not receive an affirmative vote of a majority of the shares cast.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534525/000168316823008731/0001683168-23-008731-index.htm
- Shareholder Votes
  Xenetic Biosciences, Inc. shareholders approved Ratification of selection of Marcum LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-12-06 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-12-06
  source text: The Company’s stockholders voted upon and approved the ratification of the selection of Marcum LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534525/000168316823008731/0001683168-23-008731-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.